News About: Pharm. Industry
Yungjin offers apology for Coenzyme Q10 patent infringement
Yungjin Pharm admitted that it has violated Coenzyme Q10-related patent Daewoong Chemical and Daewoong Pharm has owned and carried its apology in trade papers.
Last year, Daewoong filed a suit against Yungjin over ...
Choongwae favors "stock-holding company" system.
Following Green Cross and Daewoong in the pharmaceutical industry, Choongwae has shown a favorable attitude for the new company governing system called "stock-holding company" system.
Choongwae plans to establish C...
Government to exclude cataplasma from health insurance coverage
The government plans to ask the national health insurance to exclude cataplasma preparations in patients without gastrointestinal disorder.
Recently, the Ministry of Health and Welfare unveiled a set of measures to...
Korea Kolmar, Cosmax to expand presence in pharmaceutical market
Two leading cosmetic makers, Korea Kolmar and Comax, are stepping up their presence in the domestic pharmaceutical market.
Korea Kolmar plans to achieve their target sales of 100 billion won this year by developing...
Sanofi-Aventis Korea to launch 2007 osteoporosis awareness campaign
Starting May 2, Sanofi-Aventis Korea will begin its free check-up campaign for osteoporosis in 35 hospitals nationwide for two months, as part of its efforts to raise awareness of risk factors for osteoporosis in all ...
High productivity: key to survive under new FTA conditions.
Samsung economic research institute (SERI) predicted that to survive under the KORUS FTA conditions the pharmaceutical industry should be transformed by a proactive leadership of the generic drug company with high pro...
Pharmaceutical stocks draw growing buy interest
Increased gains of Yuhan Corporation and other drug makers on a broader market rally have raised hopes that pharmaceutical stocks will outperform the market hit by a recent FTA and a government-led new drug pricing po...
Pharmpay service system angers wholesalers in Seoul
Drug wholesalers in Seoul will have to bear an additional card commission fee of 1.8 percent to Shinhan Bank as pharmacists in Seoul will initiate their new Pharmpay service from April 30.
The association plans to ...
Lilly Korea to expand presence in lung cancer market
Lilly Korea plans to expand its presence in domestic lung cancer market as the national health insurance has covered ALIMTA (pemetrexed) from this April, following GEMZAR (gemcitabine).
Consistent evidence across t...
8 in 10 Korean business corporations satisfied with FTA outcomes.
8 in 10 local business corporations expressed their satisfaction about the KORUS FTA settlement according to the Federation of Korean Industries (FKI) survey against 100 local industries under the title of "Satisfacti...
